POLA BAKTERI PENYEBAB SEPSIS DAN KEPEKAANNYA TERHADAP ANTIBIOTIK DI RUMAH SAKIT DAERAH GUNUNG JATI PERIODE 1 JANUARI-31 DESEMBER 2022

Authors

  • Chandra Eka Ramadhani Fakultas Kedokteran UGJ Cirebon, Indonesia
  • Muhammad Hussein Gasem Fakultas Kedokteran UGJ Cirebon, Indonesia
  • Mohammad Erwin Indrakusuma Fakultas Kedokteran UGJ Cirebon, Indonesia
  • Nihayatul Amaliah Fakultas Kedokteran UGJ Cirebon, Indonesia
  • Rose Indriyati Fakultas Kedokteran UGJ Cirebon, Indonesia

Keywords:

Pola Bakteri, Kepekaan Antibiotik, Sepsis

Abstract

Latar Belakang: Prevalensi 2017 sepsis didunia 48,9 juta dengan mortalitas 11 juta kasus. Pola bakteri penyebab
sepsis dan kepekaan antibiotik sangat penting mencegah resistensi dan meningkatnya mortalitas. Tujuan:
Mempelajari pola persebaran bakteri dan kepekaannya terhadap antibiotik di Rumah Sakit Daerah (RSD) Gunung
Jati. Metode: Data retrospektif berupa rekam medis, hasil pemeriksaan kultur darah dan uji kepekaan antibiotik
dari pasien yang dicurigai sepsis di RSD Gunung Jati selama periode 1 Januari-31 Desember 2022. Penelitian
dilaksanakan pada April-Juli tahun 2023. Analisis data dengan World Health Organization (WHO) Net versi 2023
sesuai Pedoman Penyusunan Antibiogram Nasional tahun 2022. Hasil: Tiga bakteri terbanyak penyebab sepsis
adalah bakteri Gram Negatif; Escherichia coli 26 (24,5%), Klebsiella pneumoniae 18 (17%) dan bakteri Gram
Positif; Staphylococcus auereus 20 (18,9%). Uji kepekaan antibiotik dengan tingkat Susceptible (≥75 %) pada
Gram Positif; Amikacin (100%), Linezolid (92%), Rifampicin (87,5%), Vancomycin (84,6%) dan
Trimethoprim/Sulfamethoxazol (76,2%) sedangkan pada Gram Negatif; Meropenem (96,1%), Ertapenem
(89,8%), Amikacin (88,5%) dan Cefepime (76%). Simpulan: Bakteri penyebab sepsis terbanyak adalah
Escherichia coli, Stapylococcus aureus dan Klebsiella pneumoniae. Profil kepekaan antibiotik yang baik (≥75 %)
pada bakteri Gram Positif; Amikacin, Linezolid, Rifampicin, Vancomycin dan Trimethoprim/Sulfamethoxazol
sedangkan pada bakteri Gram Negatif; Meropenem, Ertapenem, Amikacin dan Cefepime.
Kata Kunci: Pola Bakteri, Kepekaan Antibiotik, Sepsis

References

Gyawali B, Ramakrishna K, Dhamoon As. Sepsis: The Evolution in Definition, Pathophysiology, and

Management. Sage Open Medicine. 2019; 7(7).

Organization Wh. Global Report on The Epidemiology and Burden of Sepsis: Current Evidence, Identifying

Gaps and Future Directions. World Health Organization; 2020.

Dharmawan A, Istia Mj, Tan Ht, Suparto S, Anastasia Mc, Layanto N. The Outcome of Patients with Sepsis

at Tarakan Hospital Central Jakarta in 2018. Muhammadiyah Medical Journal. 2021; 2(2): 49-54.

Umemura Y, Ogura H, Takuma K, Fujishima S, Abe T, Kushimoto S, et al. Current Spectrum of Causative

Pathogens in Sepsis: A Prospective Nationwide Cohort Study in Japan. International Journal of Infectious

Diseases. 2021; 103: 343-51.

Kumar S, Kabi A, Mohanty A, Singh V, Jha M, Gupta P. Clinical Spectrum and Risk Factors for HospitalAcquired Septicemia in a Tertiary Care Centre of North-East India. Journal Of Family Medicine and Primary

Care. 2020; 9(8): 3949.

Dolin HH, Papadimos TJ, Chen X, Pan ZK. Characterization of Pathogenic Sepsis Etiologies and Patient

Profiles: A Novel Approach to Triage and Treatment. Microbiology Insights. 2019.

Niederman Ms, Baron Rm, Bouadma L, Calandra T, Daneman N, Dewaele J, et al. Initial Antimicrobial

Management of Sepsis. Critical Care. 2021; 25(1).

Rehman ZU, Shah MH, Afridi MNS, Sardar H, Shiraz A. Bacterial Sepsis Pathogens and Resistance Patterns

in a South Asian Tertiary Care Hospital. Cureus. 2021; 13(5).

Amelia Sri, Fakhrur Rozi M, Balatif Ridwan. Detection of Methicillin-Resistant Staphylococcus aureus

(MRSA) Using Modified Conventional Cefoxitin-Based Media as an Alternative Screening. Journal of Pure

and Applied Microbiology. 2023.

Onduru OG, Aboud S, Nyirenda TS, Rumisha SF, Mkakosya RS. Antimicrobial Susceptibility Testing

Profiles of ESBL-Producing Enterobacterales Isolated from Hospital and Community Adult Patients in

Blantyre, Malawi. IJID Regions. 2021: 47-52.

Naqid IA, Balatay AA, Hussein NR, Saeed KA, Ahmed HA, Yousif SH. Antibiotic Susceptibility Pattern of

Escherichia coli Isolated from Various Clinical Samples in Duhok City, Kurdistan Region of Iraq.

International Journal of Infection. 2020; 7(3).

Daga AP, Koga VL, Soncini JGM, de Matos CM, Perugini MRE, Pelisson M, et al. Escherichia coli

Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics.

Frontiers in Cellular and Infection Microbiology. 2019; 9.

Hung PN, Quyet D, Thanh KC, Pho DC, Tien TV, Dung QA, et al. Antibiotic Resistance Profile and Diversity

of Subtypes Genes in Escherichia coli Causing Bloodstream Infection in Northern Vietnam. Open Access

Macedonian Journal of Medical Sciences. 2019; 7(24): 4393-8.

Aslam N, Kiran N, Mehdi N, Izhar M, Zia T, Hafsa HT. Frequency of Staphylococcus Aureus in Blood Stream

Infections and Their Drug Susceptibility Pattern. Gomal Journal of Medical Sciences. 2019; 17(1): 19-22.

Xiao S, Chen T, Wang H, Zeng Q, Chen Q, Yang Z, et al. Drug Susceptibility and Molecular Epidemiology

of Klebsiella pneumoniae Bloodstream Infection in ICU Patients in Shanghai, China. Frontiers in Medicine.

; 8

Downloads

Published

2024-07-18

Citation Check